1. Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing. Issue 10 (9th November 2020) Authors: Dodick, David W.; Gottschalk, Christopher; Cady, Roger; Hirman, Joe; Smith, Jeff; Snapinn, Steve Journal: Headache Issue: Volume 60:Issue 10(2020) Page Start: 2220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗